منوی اصلی

پروفایل استاد

دکتر مجید - داوری

مشاهده گروه
مرتبه علمی استادیار
رشته تحصیلی اقتصاد سلامت
سابقه فعالیت 1392
شماره تماس 64121540
شماره فکس 66482606
فایل مورد نظر خود را جستجو کنید
ارسال پیغام جدید
مشاهده پیام نام استاد تاریخ ارسال وضعیت پیغام

ioeconomic   status and cardiovascular disease risk factors; A novel approach to determine   this association.
Davari, M. Maracy, MR. Khorasani, E.
ARYA   Atherosclerosis. 2018 ( in press)
2018
The Effectiveness of Trastuzumab as Adjuvant therapy   in patients with Early Stage Breast Cancer: asystematic review and   meta-analysis 
Davari M. Mokariyan, M. Heidarzade, N. Hosseini, M
Medical Journal of the Islamic Republic of Iran. (in   press)
2017
Evaluation   of equity in access   to pharmaceutical services in selected cites of Isfahan province (Iran).
 Davari, M. KhorasaniE. Aslani A.
 Journal of Pharmacoeconomics and   Pharmaceutical Management.; 2(1-2): 25-9
2016
 Health Care Resource   Utilization and Cost of Care for Haemophilia A and B Patients in Iran. Gharib-Naseri, Z. Davari, M. Cheraghali, A-M   Transfusion and Apheresis Science. 54 (1): 122-6 
 
2016
The direct medical costs of   outpatient cares of type 2 diabetes in Iran; A retrospective studyDavari, M. Amini M. Hosseini, M. et.al International Journal of Preventive Medicine, 2016,4; 7:72
2016
. Measuring equity in access to pharmaceutical   services using concentration curve; model development.Davari   M. Khorasani E. Bakhshizade Z.    Jafarian M.  Ghaffari M. Maracy   M.R Iranian J of Pharmaceutical Research,14 (4): 1317-1326
2016
The   direct medical costs of acute lymphocytic leukemia (ALL) in children in   Isfahan, Iran.   Davari M. Moafi A. Yarmohammadian M.H. Khayyam E. Health   Information Management, 11(7):1057.
2015
Cost   –effectiveness analysis of Cetuximab in treatment of colorectal cancer in   Iranian pharmaceutical market.Davari M. Ashrafi F. Maracy M.R. Aslani A. Tabatabaei M.R. International Journal of Preventive   Medicine,6:63.
2015
Does   Family Physician Programme in Iran Improve Financial Contribution of the   patients. Khadivi, R. Kheyri M. Davari, M. Nourbakhsh SK; International Journal   of Current Life Sciences - Vol.4, Issue, 8, pp. 4383-4387, August, 
2014
A   HTA system for Iran, luxury or a real need; Davari, M. Walley, T., Haycox, A. Health Information   Management, 10 (6), 887-900
2014
The Direct Medical Costs of Breast Cancer in Iran:   Analyzing the Patient’s Level Data from a Cancer Specific Hospital in   Isfahan.Davari, M. Yazdanpanah F, Aslani A, Hosseini M, Nazari AR, Mokarian F.International Journal of Preventive   Medicine; 4:748-54
2013
Cost-Effectiveness Analysis of Radiotherapy Devices   in Iran. Davari M. Hadizade G. Kolahdouzan F. et al
In The Collection of Health Technology Assessment Reports in Iran; Salehi-Zolali G. Oliyaee-Manesh A. Doaei S. et al, Volume 2,
2013
The direct medical costs of colorectal cancer in   Iran; analyzing   the patient's level data from a cancer specific hospital in Isfahan. Davari, M. Emami, M.H. Maracy, M.R. et.al.
International Journal of   Preventive Medicine, 3 (12), 887-892
2012
The   Iranian Health Insurance system; past experiences, present challenges and   future strategies; Davari, M. Haycox, A. Walley, T.
Iranian   Journal of Public Health, 41 (9), 1-9
2012
. Health   care financing in Iran; is privatisation a good solution? Davari, M. Haycox, A. Walley, T Iranian Journal of Public Health 41 (7), 14-23
2012
an   appropriate tool for policy makers or just a new field of research in Iran? Davari, M.Pharmacoeconomics; Iranian J of Pharmaceutical   Research, 11 (1): 1-2
2012
The economic   challenges of health system in Iran; Davari, M.Health   Information Management, 2012, 8 (7), 915-917
2012
. Relationship between socioeconomic factors and request forcaesarean delivery in nulliparous women in   Niknafs educational health centre of Rafsanjan. Davari, M. Maracy, M.R. Mokhtari, M. Ghorashi Z
Health   InformationManagement, 8 (7), 958-965
2012
The   estimation of direct medical costs of treating patients with chronic   hepatitis B and C in Iran. Kalantari, H. Davari, M. Akbari, M. et al.
International Journal of Preventive Medicine; 3: 191-6
2012
Promoting the   efficient use of human resources in reproductive health services in Iran; a   Cost-service analysis. Davari, M. Kohan, S. Enjezab, B. Javadnouri, M.
Health Information Management, 8 (7), 929-937
2012
Sensitivity and Specificity of Colorectal Cancer   Mass Screening Methods: A Systematic Review of the Literature. Allame, Z. Davari, M. Imami, M.
 Iranian Journal of Cancer prevention, 2:88-105
 
2011
Pharmaceutical   policy and market in Iran, past experiences and future challenges;Davari M. Walley T. Haycox A.
Journal of Pharmaceutical Health Services Research, 2, 47-52
2011
Cost-Effectiveness   Analysis of Colorectal Cancer Screening Methods in the Iran; Allame, Z. Davari, M. Imami, M.
Archive of Iranian Medicine, 14 (2), 110-114
2011
. Does the Iranian Health System Need a Health Technology Assessment Programme to Improve Effectiveness, Efficiency and Equity of Its Healthcare Services?, Davari, M
PhD Thesis, University of Liverpool, UK.
2008
HEALTH   CARE CHALLENGES IN IRAN. Davari, M. Haycox, A., Walley, T.
Iranian Journal of Public Health,, Suppl, pp 30
2005
N.I.C.E   lessons for Iran. Davari, M. Haycox, A., Walley, T.
(Letter) Cellular & Molecular Biology letters,. Vol 9, Suppl 2, pp 23-24.
2004


1373-1365

دکترای    داروسازی

دانشگاه ع پ    اصفهان، اصفهان، ایران

1386-1382

دکترای    تخصصی

دانشگاه    لیورپول، ایورپول، انگلستان




تاریخ

عنوان فعالیت

محل فعالیت

تاکنون-1396

مدیرروابط   بین الملل، سازمان غذا و دارو  کنترل   کیفیت 

سازمان غذا   و دارو، وزارت بهداشت، درمان و آموزش پزشکی

تاکنون-1396

سردبیر مجله   اقتصاد و مدیریت دارو

دانشگاه ع پ   تهران

تاکنون-1395

معاون گروه 

گروه اقتصاد   و مدیریت دارو 

تاکنون-1395

عضو هیات   ممتحنه رشته اقتصاد و مدیریت دارو

وزارت   بهداشت، درمان و آموزش پزشکی

تاکنون-1395

عضو هیات   ممتحنه رشته ارزیابی فنآوری سلامت 

وزارت   بهداشت، درمان و آموزش پزشکی

تاکنون-1394

عضو مرکز   تحقیقات مدیریت و اقتصاد دارو

دانشگاه ع پ   تهران

1395-1393

معاون فنی و   برنامه ریزی، دفتر ارزیابی فن آوری، استاندارد و تعرفه سلامت

وزارت   بهداشت، درمان و آموزش پزشکی



 

    • (اقتصاد و مدیریت دارو)

      • ( ارزیابی های اقتصادی دارو)
      • ( ارزیابی کارآمدی سیاستها و برنامه ها )
      • (ارزیابی عدالت برنامه ها و سیاستها )

100 %